Collectively, these data support the hypothesis that oxidative stress and chronic low-grade inflammation are exacerbated in the intestine of insulin-resistant subjects, which may contribute to reducing local insulin sensitivity while promoting intestinal dysregulation leading to postprandial dyslipidemia. The gene discussed is INS; the disease is metabolic syndrome.